Li MM - Search Results

1

[Predictive value of serial platelet function testing on outcome in patients undergoing complex percutaneous coronary intervention].

Li MM, Li Q, Ren XJ, Yu XP, He JQ, Gao YC, Wu CY, Luo YW, Zhang YC, Chen F, Zhang XL. Li MM, et al. Among authors: li q. Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Sep 24;45(9):770-776. doi: 10.3760/cma.j.issn.0253-3758.2017.09.008. Zhonghua Xin Xue Guan Bing Za Zhi. 2017. PMID: 29036975 Chinese.

2

Identification of a pyroptosis related gene signature for predicting prognosis and estimating tumor immune microenvironment in bladder cancer.

Zhao J, Wu C, Wang Y, Li M, Jiang Y, Luo Y. Zhao J, et al. Transl Cancer Res. 2022 Jul;11(7):1865-1879. doi: 10.21037/tcr-22-177. Transl Cancer Res. 2022. PMID: 35966309 Free PMC article.

3

[The success rate of His-Purkinje system pacing in patients with various sites of atrioventricular block].

Gao Y, Li MM, Yu HB, Xu GQ, Xu BG, Wu M, Wang N, Liang YC, Wang YL, Han Y. Gao Y, et al. Among authors: li mm. Zhonghua Xin Xue Guan Bing Za Zhi. 2022 Jun 24;50(6):543-548. doi: 10.3760/cma.j.cn112148-20220403-00238. Zhonghua Xin Xue Guan Bing Za Zhi. 2022. PMID: 35705462 Chinese.

4

Overexpression of CXCR7 is a Novel Indicator for Enzalutamide Resistance in Castration-Resistant Prostate Cancer Patients.

Luo Y, Li Q, Yang X, Wei D, Feng B, Li M, Han Y, Zhao J, Lin Y, Li Q, Hou Z, Zhuang H, Jiang Y. Luo Y, et al. Dis Markers. 2021 Aug 6;2021:6649579. doi: 10.1155/2021/6649579. eCollection 2021. Dis Markers. 2021. PMID: 34413914 Free PMC article.

5

Immunogenomic Analyses of the Prognostic Predictive Model for Patients With Renal Cancer.

Feng T, Zhao J, Wei D, Guo P, Yang X, Li Q, Fang Z, Wei Z, Li M, Jiang Y, Luo Y. Feng T, et al. Front Immunol. 2021 Oct 12;12:762120. doi: 10.3389/fimmu.2021.762120. eCollection 2021. Front Immunol. 2021. PMID: 34712244 Free PMC article.

6

Hypoxia inducible factor-1α-dependent epithelial to mesenchymal transition under hypoxic conditions in prostate cancer cells.

Li M, Wang YX, Luo Y, Zhao J, Li Q, Zhang J, Jiang Y. Li M, et al. Oncol Rep. 2016 Jul;36(1):521-7. doi: 10.3892/or.2016.4766. Epub 2016 Apr 25. Oncol Rep. 2016. PMID: 27108616

7

Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer.

Luo Y, Li M, Qi H, Zhao J, Han Y, Lin Y, Hou Z, Jiang Y. Luo Y, et al. World J Surg Oncol. 2018 Jun 11;16(1):107. doi: 10.1186/s12957-018-1395-5. World J Surg Oncol. 2018. PMID: 29890979 Free PMC article.

8

Adjuvant chemotherapy after radical nephroureterectomy improves the survival outcome of high-risk upper tract urothelial carcinoma patients with cardiovascular comorbidity.

Luo Y, Feng B, Wei D, Han Y, Li M, Zhao J, Lin Y, Hou Z, Jiang Y. Luo Y, et al. Sci Rep. 2020 Oct 19;10(1):17674. doi: 10.1038/s41598-020-74940-x. Sci Rep. 2020. PMID: 33077839 Free PMC article. Clinical Trial.

9

Construction of enzalutamide-resistant cell model of prostate cancer and preliminary screening of potential drug-resistant genes.

Feng T, Wei D, Zhao J, Li Q, Guo P, Yang X, Li M, Jiang Y, Luo Y. Feng T, et al. Exp Biol Med (Maywood). 2021 Aug;246(15):1776-1787. doi: 10.1177/15353702211012625. Epub 2021 May 25. Exp Biol Med (Maywood). 2021. PMID: 34034559 Free PMC article.

10

MicroRNA‑149 inhibits cancer cell malignant phenotype by regulating Akt1 in C4‑2 CRPC cell line.

Zhao J, Li Q, Feng B, Wei D, Han Y, Li M, Wang Y, Luo Y, Jiang Y. Zhao J, et al. Oncol Rep. 2021 Dec;46(6):258. doi: 10.3892/or.2021.8209. Epub 2021 Oct 26. Oncol Rep. 2021. PMID: 34698359 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

870 results

Search Page

Filters